Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Obstetrics/Gynecology (Women’s Health) | Family Medicine
 Disease Category: Breast Cancer
Location: United States, OR

Trial Information

Women of 18 years or older with histologically proven breast cancer, eligible for neoadjuvant or adjuvant TAC chemotherapy

This study will address the prevention of neutropenic (abnormally low level of neutrophils in the blood) complications in breast cancer patients receiving chemotherapy

Patient Inclusion Criteria

  • Adequate bone marrow function on Cycle 1 Day 1 prior to chemotherapy administration
  • Estimated life expectancy of more than six months
  • For all women of childbearing potential: negative serum pregnancy test within seven days prior to randomization, and using a highly effective method of birth control

Patient Exclusion Criteria

  • Prior bone marrow or stem cell transplant
  • Concurrent prophylactic antibiotics

Toni Myers, RN
Clinical Trials of America, Inc
10 Coburg Rd., Suite 200
Eugene, OR 97401
Phone: 541-349-0523
Email: tonim@ctofa.com

View Map

Research Center Information: Clinical Trials of America, Inc

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.